Processa Pharmaceuticals Inc (PCSA) earnings · $5.9M cap
These earnings events as JSON? API free 100/dayProcessa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
This PCSA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PCSA revenue for 2022-12-31 was $0. Net income was -$27.4M. PCSA currently screens at market cap $5.9M.
When the next PCSA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for PCSA. We will not invent a beat or miss.
Not investment advice. Full PCSA research stays on the stock page; the tape stays on the quote page.
PCSA earnings FAQ
What is PCSA's latest net income?
Latest cached Processa Pharmaceuticals Inc (PCSA) net income was -$27.4M. Statements: https://lician.com/financials/pcsa
What is PCSA's latest diluted EPS?
Latest cached Processa Pharmaceuticals Inc (PCSA) diluted EPS for Dec 31, 2022 was -$34.05.
What period does the latest PCSA earnings print cover?
The latest cached Processa Pharmaceuticals Inc (PCSA) earnings print covers Dec 31, 2022.
Where are PCSA earnings listed?
Cached earnings facts for Processa Pharmaceuticals Inc (PCSA) are listed at https://lician.com/earnings/pcsa. Statements: https://lician.com/financials/pcsa
Not investment advice.